Antoni Sicras-Mainar - JoVE Visualize

Showing results (51-60 of 118) with videos related to

Pageof 12

Sort By:

Therapeutic Advances in Musculoskeletal Disease|September 30, 2020

Health outcomes and costs in patients with osteoarthritis and chronic pain treated with opioids in Spain: the OPIOIDS real-world studyAntoni Sicras-Mainar, Carlos Tornero-Tornero, Francisco Vargas-Negrín, et al.

Journal of Medical Economics|January 21, 2020

Real-life retrospective observational study to determine the prevalence and economic burden of severe asthma in SpainAntoni Sicras-Mainar, Margarita Capel, Ruth Navarro-Artieda, et al.

Global & Regional Health Technology Assessment|January 11, 2023

Clinical and economic consequences of ozenoxacin vs. other topical antibiotics for the treatment of impetigo: a real-life study in SpainJaime Rodríguez-Quintosa, Cintia Cristina Ago, Antoni Sicras-Mainar, et al.

Advances in Therapy|January 7, 2014

Pharmacoeconomic outcomes for pregabalin: a systematic review in neuropathic pain, generalized anxiety disorder, and epilepsy from a Spanish perspectiveJosep Darbà, Lisette Kaskens, Concepción Pérez, et al.

Chest|July 5, 2022

Clinical Characteristics, Treatment Persistence, and Outcomes Among Patients With COPD Treated With Single- or Multiple-Inhaler Triple Therapy: A Retrospective Analysis in SpainBernardino Alcázar-Navarrete, Lucía Jamart, Joaquín Sánchez-Covisa, et al.

BMC Infectious Diseases|November 2, 2012

Retrospective epidemiological study for the characterization of community- acquired pneumonia and pneumococcal pneumonia in adults in a well-defined area of Badalona (Barcelona, Spain)Antoni Sicras-Mainar, Jordi Ibáñez-Nolla, Isabel Cifuentes, et al.

BMC Health Services Research|November 20, 2009

Pharmaceutical cost control in primary care: opinion and contributions by healthcare professionalsAlexandra Prados-Torres, Amaia Calderón-Larrañaga, Antoni Sicras-Mainar, et al.

International Journal of Chronic Obstructive Pulmonary Disease|June 14, 2023

Impact of COPD Exacerbations and Burden of Disease in Spain: AVOIDEX StudyJuan José Soler-Cataluña, José Luis Izquierdo, Mónica Juárez Campo, et al.

Revista Espanola De Sanidad Penitenciaria|February 10, 2025

Impact of potential multiple drug-drug interactions on the adverse event profile of patients with hepatitis C treated with pangenotypic direct-acting antivirals in SpainJuan Turnes, Antonio García-Herola, Ramón Morillo-Verdugo, et al.

Pharmaceuticals (Basel, Switzerland)|November 25, 2023

Comprehensive Observational Study in a Large Cohort of Asthma Patients after Adding LAMA to ICS/LABAVicente Plaza, Javier Domínguez-Ortega, Diego González-Segura Alsina, et al.

Pageof 12

Showing results (51-60 of 118) with videos related to

Sort By:

Pageof 12

Therapeutic Advances in Musculoskeletal Disease|September 30, 2020

Health outcomes and costs in patients with osteoarthritis and chronic pain treated with opioids in Spain: the OPIOIDS real-world studyAntoni Sicras-Mainar, Carlos Tornero-Tornero, Francisco Vargas-Negrín, et al.

Journal of Medical Economics|January 21, 2020

Real-life retrospective observational study to determine the prevalence and economic burden of severe asthma in SpainAntoni Sicras-Mainar, Margarita Capel, Ruth Navarro-Artieda, et al.

Global & Regional Health Technology Assessment|January 11, 2023

Clinical and economic consequences of ozenoxacin vs. other topical antibiotics for the treatment of impetigo: a real-life study in SpainJaime Rodríguez-Quintosa, Cintia Cristina Ago, Antoni Sicras-Mainar, et al.

Advances in Therapy|January 7, 2014

Pharmacoeconomic outcomes for pregabalin: a systematic review in neuropathic pain, generalized anxiety disorder, and epilepsy from a Spanish perspectiveJosep Darbà, Lisette Kaskens, Concepción Pérez, et al.

Chest|July 5, 2022

Clinical Characteristics, Treatment Persistence, and Outcomes Among Patients With COPD Treated With Single- or Multiple-Inhaler Triple Therapy: A Retrospective Analysis in SpainBernardino Alcázar-Navarrete, Lucía Jamart, Joaquín Sánchez-Covisa, et al.

BMC Infectious Diseases|November 2, 2012

Retrospective epidemiological study for the characterization of community- acquired pneumonia and pneumococcal pneumonia in adults in a well-defined area of Badalona (Barcelona, Spain)Antoni Sicras-Mainar, Jordi Ibáñez-Nolla, Isabel Cifuentes, et al.

BMC Health Services Research|November 20, 2009

Pharmaceutical cost control in primary care: opinion and contributions by healthcare professionalsAlexandra Prados-Torres, Amaia Calderón-Larrañaga, Antoni Sicras-Mainar, et al.

International Journal of Chronic Obstructive Pulmonary Disease|June 14, 2023

Impact of COPD Exacerbations and Burden of Disease in Spain: AVOIDEX StudyJuan José Soler-Cataluña, José Luis Izquierdo, Mónica Juárez Campo, et al.

Revista Espanola De Sanidad Penitenciaria|February 10, 2025

Impact of potential multiple drug-drug interactions on the adverse event profile of patients with hepatitis C treated with pangenotypic direct-acting antivirals in SpainJuan Turnes, Antonio García-Herola, Ramón Morillo-Verdugo, et al.

Pharmaceuticals (Basel, Switzerland)|November 25, 2023

Comprehensive Observational Study in a Large Cohort of Asthma Patients after Adding LAMA to ICS/LABAVicente Plaza, Javier Domínguez-Ortega, Diego González-Segura Alsina, et al.

Pageof 12